| 主权项 |
1. A method of treating one or more symptoms of a SHC-1/p66-related disease selected from the group consisting of aging, diabetes, and reperfusion injuries after ischemia comprising administering a polymeric composition comprising monomer units having formula I and/or a pharmaceutically acceptable salt, solvate, or prodrug thereof: to a mammal in need thereof, wherein in Formula I, each of R1 and R2, independently, is H, alkyl, or acyl; each of R3, R4, R5, R6, and R7, independently, is H, OH, alkoxyl, or acyl; and R8 is H or a saccharide moiety; and wherein the polymerized number of the monomer ranges from 2-30, and the average molecular weight of the polymer ranges from 600-10,000. |
